[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340959-105":59,"doc-detail-340959-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","bivalent-chromatin-a-developmental-balancing-act-tipped-in-cancer","Bivalent chromatin: a developmental balancing act tipped in cancer","","Bivalent chromatin is characterized by the simultaneous presence of opposing histone modifications, H3K4me3 and H3K27me3, classically at unmethylated promoters of lowly transcribed genes. In embryonic stem cells it has been proposed to prime developmental regulators for future activation or repression during lineage commitment, while a tightly regulated balance is maintained by MLL/COMPASS-like and Polycomb repressive complexes. In cancer, altered domains and de novo bivalent states accompany transcriptional activation or silencing, potentially supporting epithelial-to-mesenchymal plasticity, chemoresistance and immune evasion. The review surveys detection methods and mechanisms governing formation and fine-tuning, and proposes bivalency as a dynamic equilibrium whose disruption tips cells into altered epigenetic and phenotypic states.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bivalent-chromatin-a-developmental-balancing-act-tipped-in-cancer/340959/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bivalent-chromatin-a-developmental-balancing-act-tipped-in-cancer/340959.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What defines bivalent chromatin at the molecular level?","Question",{"text":113,"@type":114},"Bivalent chromatin is defined by the co-occurrence of H3K4me3 and H3K27me3 on opposing histone tails within the same nucleosome.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is bivalent chromatin proposed to function in embryonic stem cells?",{"text":118,"@type":114},"It is proposed to poise developmental genes for future activation, silencing, or stable repression upon lineage commitment.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is bivalent chromatin relevant to cancer?",{"text":122,"@type":114},"Cancer is associated with deregulation of existing bivalent domains and creation of de novo bivalent states, which correlate with activation or silencing of transcriptional programs linked to cancer pathology.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340959,1790198478,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Biochemical Society Transactions (2024) 52 217–229 [https://doi.org/10.1042/BST20230426](https://doi.org/10.1042/BST20230426)  \nReview Article  \nBivalent chromatin: a developmental balancing act tipped in cancer  \nEleanor Glancy1,2, Natalie Choy1,2 and  Melanie A. Eckersley-Maslin1,2,3  \n1Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; 2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria 3010,  \nAustralia; 3Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria 3010, Australia Correspondence: Melanie A. Eckersley-Maslin ([melanie.eckersley-maslin@petermac.org](melanie.eckersley-maslin@petermac.org))  \nReceived: 21 November 2023  \nRevised: 5 February 2024  \nAccepted: 7 February 2024  \nVersion of Record published:  \n22 February 2024  \nBivalent chromatin is deﬁned by the co-occurrence of otherwise opposing H3K4me3 and H3K27me3 modiﬁcations and is typically located at unmethylated promoters of lowly transcribed genes. In embryonic stem cells, bivalent chromatin has been proposed topoise developmental genes for future activation, silencing or stable repression upon lineage commitment. Normally, bivalent chromatin is kept in tight balance in cells, in part through the activity of the MLL/COMPASS-like and Polycomb repressive complexes that deposit the H3K4me3 and H3K27me3 modiﬁcations, respectively, but also emerging novel regulators including DPPA2/4, QSER1, BEND3, TET1 and METTL14 . In cancers, both the deregulation of existing domains and the creation of de novo bivalent states is associated with either the activation or silencing of transcriptional programmes. This may facilitate diverse aspects of cancer pathology including epithelial-to-mesenchymal plasticity, chemoresistance and immune evasion. Here, we review current methods for detecting bivalent chromatin and discuss the factors involved in the formation and ﬁne-tuning of bivalent domains. Finally, we examine how the deregulation of chromatin bivalency in the context of cancer could facilitate and/or reﬂect cancer cell adaptation. We propose a model in which bivalent chromatin represents a dynamic balance between otherwise opposing states, where the underlying DNA sequence is primed for the future activation or repression. Shifting this balance in any direction disrupts the tight equilibrium and tips cells into an altered epigenetic and phenotypic space, facilitating both developmental and cancer processes.  \nIntroduction  \nCancer can be described as a disease of cellular identity and is often associated with a dedifferentiated state recapitulating epigenetic, transcriptomic and phenotypic properties associated with embryonic cells [1–3] . Emerging models propose that cancer cells can hijack developmental programmes to increase their plasticity and facilitate their evolution and adaptation [4–7] . In both cancer and development, cellular identity is controlled in part by epigenetic mechanisms, involving DNA- and chromatin-modifying complexes. These epigenetic mechanisms collaborate in a co-ordinated manner to orchestrate gene expression changes associated with differentiation and are often compromised during cancer initiation and progression [8] .  \nNucleosomes, the fundamental unit of chromatin, are comprised of histone proteins and associated DNA. Changes in histone tail modiﬁcations inﬂuence chromatin structure controlling the availability of DNA for networks of sequence-speciﬁc transcription factors [9–11] . In this review, we focus on the bivalent chromatin structure which is deﬁned by the co-occurrence of trimethylation of lysine 27 on histone-H3 (H3K27me3) and trimethylation of lysine 4 on histone-H3 (H3K4me3) on opposing tails within the same nucleosome [12, 13] (Figure 1) . Generally, these two marks are associated with gene repression and activation respectively. However, their co-occurrence at lowly transcribed promoters occupied by paused RNA Polymerase II has been docum","cbCaimP1pFJ3oJPt","https://ap.wps.com/l/cbCaimP1pFJ3oJPt","pdf",885523,"English","# Introduction\n## Cancer and cellular identity\n## Bivalent chromatin structure and marks\n## Developmental and cross-species conservation\n# Bivalent chromatin in mammalian genomes","[{\"question\":\"What defines bivalent chromatin at the molecular level?\",\"answer\":\"Bivalent chromatin is defined by the co-occurrence of H3K4me3 and H3K27me3 on opposing histone tails within the same nucleosome.\"},{\"question\":\"How is bivalent chromatin proposed to function in embryonic stem cells?\",\"answer\":\"It is proposed to poise developmental genes for future activation, silencing, or stable repression upon lineage commitment.\"},{\"question\":\"Why is bivalent chromatin relevant to cancer?\",\"answer\":\"Cancer is associated with deregulation of existing bivalent domains and creation of de novo bivalent states, which correlate with activation or silencing of transcriptional programs linked to cancer pathology.\"}]","Bivalent chromatin: a developmental balancing act tipped in cancer | PDF",1790039689,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad42563317e55dca6cdbec140dac611b.webp",983,1301,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/088d24da5045fb940bc4fedd4555e36a.webp",982,1299,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77018080f63783e744c43567b830ae4a.webp",981,1298,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f66b2b92979d87135b4ad289c96cf56c.webp",980,1297]